Skip to main content

Table 2 Uropathogens characteristics and disease recurrences

From: Chronic bacterial prostatitis: efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox®) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens®)

 

Group A

Group B

Uropathogens (baseline) (%)

  

Gram negative

41 (53.9)

39 (50.6)

  Escherichia coli

33 (80.5)

33 (84.6)

  Proteus mirabilis

3 (7.3)

1 (2.6)

  Klebsiella spp.

7 (17.1)

5 (12.8)

  Serratta spp.

2 (4.88)

4 (10.3)

  Pseudomonas aeruginosa

0 (0)

0 (0)

  Enterobacter spp.

20 (48.8)

15 (38.5)

Gram positive

35 (46.1)

38 (49.4)

  Enterococcus spp.

25 (71.4)

27 (71)

  Staphylococcus saprophyticus

10 (28.6)

10 (26.3)

  Staphylococcus epidermidis

2 (5.7)

4 (10.5)

  Staphylococcus aureus

1 (2.8)

0 (0)

  Streptococcus B group

6 (17.1)

4 (10.5)

Recurrences (2 months) (%)

21 (27.6)

6 (7.8)

Uropathogens (2 months) (%)

  

Gram negative

21 (95.4)

6 (100)

  Escherichia coli

17 (81)

4 (66.7)

  Proteus mirabilis

0 (0)

0 (0)

  Klebsiella spp.

2 (9.5)

1 (16.7)

  Serratta spp.

0 (0)

0 (0)

  Pseudomonas aeruginosa

0 (0)

0 (0)

  Enterobacter spp.

2 (9.5)

1 (16.7)

Gram positive

1 (4.5)

0 (0)

  Enterococcus spp.

1 (100)

0 (0)

  Staphylococcus saprophyticus

0 (0)

0 (0)

  Staphylococcus epidermidis

0 (0)

0 (0)

  Staphylococcus aureus

0 (0)

0 (0)

  Streptococcus B group

0 (0)

0 (0)